Cargando…

Disability-adjusted life years for respiratory syncytial virus in children under 2 years

BACKGROUND: Respiratory syncytial virus infection is the leading cause of bronchiolitis in Colombia. There is growing evidence about the impact of Respiratory syncytial virus on society in terms of years of life lost due to this condition. The objective of the present study is to determine the Disab...

Descripción completa

Detalles Bibliográficos
Autores principales: Villamil, Juana Patricia Sánchez, Polack, Fernando P., Buendía, Jefferson Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654061/
https://www.ncbi.nlm.nih.gov/pubmed/33167966
http://dx.doi.org/10.1186/s12889-020-09796-x
_version_ 1783608003074719744
author Villamil, Juana Patricia Sánchez
Polack, Fernando P.
Buendía, Jefferson Antonio
author_facet Villamil, Juana Patricia Sánchez
Polack, Fernando P.
Buendía, Jefferson Antonio
author_sort Villamil, Juana Patricia Sánchez
collection PubMed
description BACKGROUND: Respiratory syncytial virus infection is the leading cause of bronchiolitis in Colombia. There is growing evidence about the impact of Respiratory syncytial virus on society in terms of years of life lost due to this condition. The objective of the present study is to determine the Disability-Adjusted Life Years for respiratory syncytial virus in children under 2 years in Colombia. METHODS: Data from the national epidemiological surveillance system were used to estimate DALYs, calculated from the sum of years of life lost and years lived with disability due to RSV infection in Colombia. A bootstrapped method with 10,000 iterations was used to estimate each statistical parameter using the package DALY calculator in R. RESULTS: In 2019, 260,873 years of life (CI95% 208,180–347,023) were lost due to RSV bronchiolitis in Colombian children under 2 years. The estimated rate was 20 DALYs / 1000 person-year (95% CI 16–27). CONCLUSION: This is the first report estimating the impact of RSV bronchiolitis morbidity and mortality in Colombia. The findings of the present study suggest that the actual burden and cost of bronchiolitis due to RSV is high. Prevention strategies, such as RSV vaccination, to reduce morbidity associated with RSV infection should be encouraged in our country.
format Online
Article
Text
id pubmed-7654061
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76540612020-11-10 Disability-adjusted life years for respiratory syncytial virus in children under 2 years Villamil, Juana Patricia Sánchez Polack, Fernando P. Buendía, Jefferson Antonio BMC Public Health Research Article BACKGROUND: Respiratory syncytial virus infection is the leading cause of bronchiolitis in Colombia. There is growing evidence about the impact of Respiratory syncytial virus on society in terms of years of life lost due to this condition. The objective of the present study is to determine the Disability-Adjusted Life Years for respiratory syncytial virus in children under 2 years in Colombia. METHODS: Data from the national epidemiological surveillance system were used to estimate DALYs, calculated from the sum of years of life lost and years lived with disability due to RSV infection in Colombia. A bootstrapped method with 10,000 iterations was used to estimate each statistical parameter using the package DALY calculator in R. RESULTS: In 2019, 260,873 years of life (CI95% 208,180–347,023) were lost due to RSV bronchiolitis in Colombian children under 2 years. The estimated rate was 20 DALYs / 1000 person-year (95% CI 16–27). CONCLUSION: This is the first report estimating the impact of RSV bronchiolitis morbidity and mortality in Colombia. The findings of the present study suggest that the actual burden and cost of bronchiolitis due to RSV is high. Prevention strategies, such as RSV vaccination, to reduce morbidity associated with RSV infection should be encouraged in our country. BioMed Central 2020-11-10 /pmc/articles/PMC7654061/ /pubmed/33167966 http://dx.doi.org/10.1186/s12889-020-09796-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Villamil, Juana Patricia Sánchez
Polack, Fernando P.
Buendía, Jefferson Antonio
Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title_full Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title_fullStr Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title_full_unstemmed Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title_short Disability-adjusted life years for respiratory syncytial virus in children under 2 years
title_sort disability-adjusted life years for respiratory syncytial virus in children under 2 years
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654061/
https://www.ncbi.nlm.nih.gov/pubmed/33167966
http://dx.doi.org/10.1186/s12889-020-09796-x
work_keys_str_mv AT villamiljuanapatriciasanchez disabilityadjustedlifeyearsforrespiratorysyncytialvirusinchildrenunder2years
AT polackfernandop disabilityadjustedlifeyearsforrespiratorysyncytialvirusinchildrenunder2years
AT buendiajeffersonantonio disabilityadjustedlifeyearsforrespiratorysyncytialvirusinchildrenunder2years